How big is the market?

BUY CHAPTERS

Global Testosterone Undecanoate Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Code: QYRE-Auto-2Z12319

Report

September 2022

Pages:105

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Bayer

Endo Pharmaceuticals

Merck Sharp & Dohme

Taro Pharmaceutical

Cipla Ltd

Zhejiang Xianju Pharmaceutical

Zhejiang Medicine Co.

Testosterone undecanoate, sold under the brand names Nebido, Aveed, and Andriol among others, is an androgen and anabolic steroid (AAS) medication which is used mainly in the treatment of low testosterone levels in men. It is also used in hormone therapy for transgender men. It is taken by mouth two to three times per day with food or given by injection into muscle once every 12 weeks or so.

Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.

The USA market for Testosterone Undecanoate is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The China market for Testosterone Undecanoate is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The Europe market for Testosterone Undecanoate is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The global key manufacturers of Testosterone Undecanoate include Bayer AG, Endo Pharmaceuticals, Merck Sharp & Dohme, Taro Pharmaceutical, Cipla, Zhejiang Xianju Pharmaceutical and Zhejiang Medicine Co., etc. In 2021, the global top five players had a share approximately % in terms of revenue.

Report Scope

This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Testosterone Undecanoate manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Testosterone Undecanoate market. Further, it explains the major drivers and regional dynamics of the global Testosterone Undecanoate market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

Bayer AG

Endo Pharmaceuticals

Merck Sharp & Dohme

Taro Pharmaceutical

Cipla

Zhejiang Xianju Pharmaceutical

Zhejiang Medicine Co.

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.

Testosterone Undecanoate Segment by Type

Injection

Oral

Testosterone Undecanoate Segment by Application

Primary Hypogonadism

Hypogonadotropic Hypogonadism

Late-Onset Hypogonadism

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Testosterone Undecanoate market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Testosterone Undecanoate, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Testosterone Undecanoate, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Testosterone Undecanoate, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Testosterone Undecanoate sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Testosterone Undecanoate market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Testosterone Undecanoate sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Bayer AG, Endo Pharmaceuticals, Merck Sharp & Dohme, Taro Pharmaceutical, Cipla, Zhejiang Xianju Pharmaceutical and Zhejiang Medicine Co., etc.

1 Report Overview

1.1 Research Scope

1.2 Market Segment by Type

1.2.1 Global Testosterone Undecanoate Market Size Growth Rate by Type (2017 VS 2021 VS 2028)

1.2.2 Injection

1.2.3 Oral

1.3 Market Segment by Application

1.3.1 Global Testosterone Undecanoate Market Share by Application (2017 VS 2021 VS 2028)

1.3.2 Primary Hypogonadism

1.3.3 Hypogonadotropic Hypogonadism

1.3.4 Late-Onset Hypogonadism

1.4 Study Objectives

1.5 Years Considered

2 Market Perspective

2.1 Global Testosterone Undecanoate Market Size (2017-2028)

2.1.1 Global Testosterone Undecanoate Revenue (2017-2028)

2.1.2 Global Testosterone Undecanoate Sales (2017-2028)

2.2 Global Testosterone Undecanoate Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028

2.2.1 Global Testosterone Undecanoate Sales by Regions (2017-2022)

2.2.2 Global Testosterone Undecanoate Revenue by Regions (2017-2022)

2.3 Global Testosterone Undecanoate Market Size Forecast by Region

2.3.1 Global Testosterone Undecanoate Sales Forecast by Region (2023-2028)

2.3.2 Global Testosterone Undecanoate Revenue Forecast by Region (2023-2028)

2.4 Global Top Testosterone Undecanoate Regions (Countries) Ranking by Market Size

2.5 Testosterone Undecanoate Market Dynamics

2.5.1 Testosterone Undecanoate Market Trends

2.5.2 Testosterone Undecanoate Market Drivers

2.5.3 Testosterone Undecanoate Market Challenges

2.5.4 Testosterone Undecanoate Market Restraints

3 Competitive Landscape by Manufacturers

3.1 Global Top Testosterone Undecanoate Manufacturers by Sales (2017-2022)

3.1.1 Global Testosterone Undecanoate Sales by Manufacturers (2017-2022)

3.1.2 Global Testosterone Undecanoate Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global 5 and 10 Largest Manufacturers by Testosterone Undecanoate Sales in 2021

3.2 Global Top Manufacturers Testosterone Undecanoate by Revenue

3.2.1 Global Testosterone Undecanoate Revenue by Manufacturers (2017-2022)

3.2.2 Top Testosterone Undecanoate Manufacturers Covered: Ranking by Revenue

3.2.3 Global Testosterone Undecanoate Revenue Share by Manufacturers (2017-2022)

3.2.4 Global Testosterone Undecanoate Market Concentration Ratio (CR5 and HHI)

3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Testosterone Undecanoate as of 2021)

3.4 Global Testosterone Undecanoate Average Selling Price (ASP) by Manufacturers

3.5 Key Manufacturers Testosterone Undecanoate Plants/Factories Distribution and Area Served

3.6 Date of Key Manufacturers Enter into Testosterone Undecanoate Market

3.7 Key Manufacturers Testosterone Undecanoate Product Offered

3.8 Mergers & Acquisitions, Expansion Plans

4 Global Testosterone Undecanoate Market Size by Type

4.1 Global Testosterone Undecanoate Historic Market Review by Type (2017-2022)

4.1.1 Global Testosterone Undecanoate Sales Market Share by Type (2017-2022)

4.1.2 Global Testosterone Undecanoate Revenue Market Share by Type (2017-2022)

4.1.3 Testosterone Undecanoate Price by Type (2017-2022)

4.2 Global Testosterone Undecanoate Market Estimates and Forecasts by Type (2023-2028)

4.2.1 Global Testosterone Undecanoate Sales Forecast by Type (2023-2028)

4.2.2 Global Testosterone Undecanoate Revenue Forecast by Type (2023-2028)

4.2.3 Testosterone Undecanoate Price Forecast by Type (2023-2028)

5 Global Testosterone Undecanoate Market Size by Application

5.1 Global Testosterone Undecanoate Historic Market Review by Application (2017-2022)

5.1.1 Global Testosterone Undecanoate Sales Market Share by Application (2017-2022)

5.1.2 Global Testosterone Undecanoate Revenue Market Share by Application (2017-2022)

5.1.3 Testosterone Undecanoate Price by Application (2017-2022)

5.2 Global Testosterone Undecanoate Market Estimates and Forecasts by Application (2023-2028)

5.2.1 Global Testosterone Undecanoate Sales Forecast by Application (2023-2028)

5.2.2 Global Testosterone Undecanoate Revenue Forecast by Application (2023-2028)

5.2.3 Testosterone Undecanoate Price Forecast by Application (2023-2028)

6 North America

6.1 North America Testosterone Undecanoate Sales Breakdown by Company

6.1.1 North America Testosterone Undecanoate Sales by Company (2017-2022)

6.1.2 North America Testosterone Undecanoate Revenue by Company (2017-2022)

6.2 North America Testosterone Undecanoate Market Size by Type

6.2.1 North America Testosterone Undecanoate Sales by Type (2017-2028)

6.2.2 North America Testosterone Undecanoate Revenue by Type (2017-2028)

6.3 North America Testosterone Undecanoate Market Size by Application

6.3.1 North America Testosterone Undecanoate Sales by Application (2017-2028)

6.3.2 North America Testosterone Undecanoate Revenue by Application (2017-2028)

6.4 North America Testosterone Undecanoate Market Size by Country

6.4.1 North America Testosterone Undecanoate Sales by Country (2017-2028)

6.4.2 North America Testosterone Undecanoate Revenue by Country (2017-2028)

6.4.3 U.S.

6.4.4 Canada

7 Europe

7.1 Europe Testosterone Undecanoate Sales Breakdown by Company

7.1.1 Europe Testosterone Undecanoate Sales by Company (2017-2022)

7.1.2 Europe Testosterone Undecanoate Revenue by Company (2017-2022)

7.2 Europe Testosterone Undecanoate Market Size by Type

7.2.1 Europe Testosterone Undecanoate Sales by Type (2017-2028)

7.2.2 Europe Testosterone Undecanoate Revenue by Type (2017-2028)

7.3 Europe Testosterone Undecanoate Market Size by Application

7.3.1 Europe Testosterone Undecanoate Sales by Application (2017-2028)

7.3.2 Europe Testosterone Undecanoate Revenue by Application (2017-2028)

7.4 Europe Testosterone Undecanoate Market Size by Country

7.4.1 Europe Testosterone Undecanoate Sales by Country (2017-2028)

7.4.2 Europe Testosterone Undecanoate Revenue by Country (2017-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

8 Asia Pacific

8.1 Asia Pacific Testosterone Undecanoate Sales Breakdown by Company

8.1.1 Asia Pacific Testosterone Undecanoate Sales by Company (2017-2022)

8.1.2 Asia Pacific Testosterone Undecanoate Revenue by Company (2017-2022)

8.2 Asia Pacific Testosterone Undecanoate Market Size by Type

8.2.1 Asia Pacific Testosterone Undecanoate Sales by Type (2017-2028)

8.2.2 Asia Pacific Testosterone Undecanoate Revenue by Type (2017-2028)

8.3 Asia Pacific Testosterone Undecanoate Market Size by Application

8.3.1 Asia Pacific Testosterone Undecanoate Sales by Application (2017-2028)

8.3.2 Asia Pacific Testosterone Undecanoate Revenue by Application (2017-2028)

8.4 Asia Pacific Testosterone Undecanoate Market Size by Region

8.4.1 Asia Pacific Testosterone Undecanoate Sales by Region

8.4.2 Asia Pacific Testosterone Undecanoate Revenue by Region

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 India

8.4.7 Australia

8.4.8 Taiwan

8.4.9 Indonesia

8.4.10 Thailand

8.4.11 Malaysia

8.4.12 Philippines

8.4.13 Vietnam

9 Latin America

9.1 Latin America Testosterone Undecanoate Sales Breakdown by Company

9.1.1 Latin America Testosterone Undecanoate Sales by Company (2017-2022)

9.1.2 Latin America Testosterone Undecanoate Revenue by Company (2017-2022)

9.2 Latin America Testosterone Undecanoate Market Size by Type

9.2.1 Latin America Testosterone Undecanoate Sales by Type (2017-2028)

9.2.2 Latin America Testosterone Undecanoate Revenue by Type (2017-2028)

9.3 Latin America Testosterone Undecanoate Market Size by Application

9.3.1 Latin America Testosterone Undecanoate Sales by Application (2017-2028)

9.3.2 Latin America Testosterone Undecanoate Revenue by Application (2017-2028)

9.4 Latin America Testosterone Undecanoate Market Size by Country

9.4.1 Latin America Testosterone Undecanoate Sales by Country (2017-2028)

9.4.2 Latin America Testosterone Undecanoate Revenue by Country (2017-2028)

9.4.3 Mexico

9.4.4 Brazil

9.4.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Testosterone Undecanoate Sales Breakdown by Company

10.1.1 Middle East and Africa Testosterone Undecanoate Sales by Company (2017-2022)

10.1.2 Middle East and Africa Testosterone Undecanoate Revenue by Company (2017-2022)

10.2 Middle East and Africa Testosterone Undecanoate Market Size by Type

10.2.1 Middle East and Africa Testosterone Undecanoate Sales by Type (2017-2028)

10.2.2 Middle East and Africa Testosterone Undecanoate Revenue by Type (2017-2028)

10.3 Middle East and Africa Testosterone Undecanoate Market Size by Application

10.3.1 Middle East and Africa Testosterone Undecanoate Sales by Application (2017-2028)

10.3.2 Middle East and Africa Testosterone Undecanoate Revenue by Application (2017-2028)

10.4 Middle East and Africa Testosterone Undecanoate Market Size by Country

10.4.1 Middle East and Africa Testosterone Undecanoate Sales by Country (2017-2028)

10.4.2 Middle East and Africa Testosterone Undecanoate Revenue by Country (2017-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Company Profiles

11.1 Bayer AG

11.1.1 Bayer AG Corporation Information

11.1.2 Bayer AG Overview

11.1.3 Bayer AG Testosterone Undecanoate Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.1.4 Bayer AG Testosterone Undecanoate Products and Services

11.1.5 Bayer AG Testosterone Undecanoate SWOT Analysis

11.1.6 Bayer AG Recent Developments

11.2 Endo Pharmaceuticals

11.2.1 Endo Pharmaceuticals Corporation Information

11.2.2 Endo Pharmaceuticals Overview

11.2.3 Endo Pharmaceuticals Testosterone Undecanoate Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.2.4 Endo Pharmaceuticals Testosterone Undecanoate Products and Services

11.2.5 Endo Pharmaceuticals Testosterone Undecanoate SWOT Analysis

11.2.6 Endo Pharmaceuticals Recent Developments

11.3 Merck Sharp & Dohme

11.3.1 Merck Sharp & Dohme Corporation Information

11.3.2 Merck Sharp & Dohme Overview

11.3.3 Merck Sharp & Dohme Testosterone Undecanoate Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.3.4 Merck Sharp & Dohme Testosterone Undecanoate Products and Services

11.3.5 Merck Sharp & Dohme Testosterone Undecanoate SWOT Analysis

11.3.6 Merck Sharp & Dohme Recent Developments

11.4 Taro Pharmaceutical

11.4.1 Taro Pharmaceutical Corporation Information

11.4.2 Taro Pharmaceutical Overview

11.4.3 Taro Pharmaceutical Testosterone Undecanoate Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.4.4 Taro Pharmaceutical Testosterone Undecanoate Products and Services

11.4.5 Taro Pharmaceutical Testosterone Undecanoate SWOT Analysis

11.4.6 Taro Pharmaceutical Recent Developments

11.5 Cipla

11.5.1 Cipla Corporation Information

11.5.2 Cipla Overview

11.5.3 Cipla Testosterone Undecanoate Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.5.4 Cipla Testosterone Undecanoate Products and Services

11.5.5 Cipla Testosterone Undecanoate SWOT Analysis

11.5.6 Cipla Recent Developments

11.6 Zhejiang Xianju Pharmaceutical

11.6.1 Zhejiang Xianju Pharmaceutical Corporation Information

11.6.2 Zhejiang Xianju Pharmaceutical Overview

11.6.3 Zhejiang Xianju Pharmaceutical Testosterone Undecanoate Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.6.4 Zhejiang Xianju Pharmaceutical Testosterone Undecanoate Products and Services

11.6.5 Zhejiang Xianju Pharmaceutical Testosterone Undecanoate SWOT Analysis

11.6.6 Zhejiang Xianju Pharmaceutical Recent Developments

11.7 Zhejiang Medicine Co.

11.7.1 Zhejiang Medicine Co. Corporation Information

11.7.2 Zhejiang Medicine Co. Overview

11.7.3 Zhejiang Medicine Co. Testosterone Undecanoate Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.7.4 Zhejiang Medicine Co. Testosterone Undecanoate Products and Services

11.7.5 Zhejiang Medicine Co. Testosterone Undecanoate SWOT Analysis

11.7.6 Zhejiang Medicine Co. Recent Developments

12 Value Chain and Sales Channels Analysis

12.1 Testosterone Undecanoate Value Chain Analysis

12.2 Testosterone Undecanoate Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Testosterone Undecanoate Production Mode & Process

12.4 Testosterone Undecanoate Sales and Marketing

12.4.1 Testosterone Undecanoate Sales Channels

12.4.2 Testosterone Undecanoate Distributors

12.5 Testosterone Undecanoate Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

14.3 Disclaimer

FEATURED COMPANIES

Bayer

Endo Pharmaceuticals

Merck Sharp & Dohme

Taro Pharmaceutical

Cipla Ltd

Zhejiang Xianju Pharmaceutical

Zhejiang Medicine Co.

List of Tables

Table 1. Global Testosterone Undecanoate Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)

Table 2. Major Manufacturers of Injection

Table 3. Major Manufacturers of Oral

Table 4. Global Testosterone Undecanoate Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)

Table 5. Global Testosterone Undecanoate Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028

Table 6. Global Testosterone Undecanoate Sales by Region (2017-2022) & (K Units)

Table 7. Global Testosterone Undecanoate Sales Market Share by Region (2017-2022)

Table 8. Global Testosterone Undecanoate Revenue by Region (2017-2022) & (US$ Million)

Table 9. Global Testosterone Undecanoate Revenue Market Share by Region (2017-2022)

Table 10. Global Testosterone Undecanoate Sales Forecast by Region (2023-2028) & (K Units)

Table 11. Global Testosterone Undecanoate Sales Market Share Forecast by Region (2023-2028)

Table 12. Global Testosterone Undecanoate Revenue Forecast by Region (2023-2028) & (US$ Million)

Table 13. Global Testosterone Undecanoate Revenue Market Share Forecast by Region (2023-2028)

Table 14. Top Testosterone Undecanoate Regions (Countries) Ranking by Market Size (US$ Million) in 2021

Table 15. Testosterone Undecanoate Market Trends

Table 16. Testosterone Undecanoate Market Drivers

Table 17. Testosterone Undecanoate Market Challenges

Table 18. Testosterone Undecanoate Market Restraints

Table 19. Global Testosterone Undecanoate Sales by Manufacturers (2017-2022) & (K Units)

Table 20. Global Testosterone Undecanoate Sales Share by Manufacturers (2017-2022)

Table 21. Global Testosterone Undecanoate Revenue by Manufacturers (2017-2022) & (US$ Million)

Table 22. Ranking of Global Top Testosterone Undecanoate Manufacturers by Revenue (US$ Million) in 2021

Table 23. Testosterone Undecanoate Revenue Share by Manufacturers (2017-2022)

Table 24. Global Testosterone Undecanoate Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 25. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Testosterone Undecanoate as of 2021)

Table 26. Key Manufacturers Testosterone Undecanoate Average Selling Price (ASP) & (2017-2022) & (USD/Unit)

Table 27. Key Manufacturers Testosterone Undecanoate Plants/Factories Distribution

Table 28. Key Manufacturers Testosterone Undecanoate Area Served

Table 29. Date of Key Manufacturers Enter into Testosterone Undecanoate Market

Table 30. Key Manufacturers Testosterone Undecanoate Product Type

Table 31. Mergers & Acquisitions, Expansion Plans

Table 32. Global Testosterone Undecanoate Sales (K Units) by Type (2017-2022)

Table 33. Global Testosterone Undecanoate Sales Share by Type (2017-2022)

Table 34. Global Testosterone Undecanoate Revenue (US$ Million) Market Share by Type (2017-2022)

Table 35. Global Testosterone Undecanoate Price (K Units) by Type (2017-2022)

Table 36. Global Testosterone Undecanoate Sales (K Units) by Type (2023-2028)

Table 37. Global Testosterone Undecanoate Sales Share by Type (2023-2028)

Table 38. Global Testosterone Undecanoate Revenue (US$ Million) Market Share by Type (2023-2028)

Table 39. Global Testosterone Undecanoate Revenue Share by Type (2023-2028)

Table 40. Global Testosterone Undecanoate Price (K Units) by Type (2023-2028)

Table 41. Global Testosterone Undecanoate Sales (K Units) by Application (2017-2022)

Table 42. Global Testosterone Undecanoate Sales Share by Application (2017-2022)

Table 43. Global Testosterone Undecanoate Revenue (US$ Million) Market Share by Application (2017-2022)

Table 44. Global Testosterone Undecanoate Price (K Units) by Application (2017-2022)

Table 45. Global Testosterone Undecanoate Sales (K Units) by Application (2023-2028)

Table 46. Global Testosterone Undecanoate Sales Share by Application (2023-2028)

Table 47. Global Testosterone Undecanoate Revenue (US$ Million) Market Share by Application (2023-2028)

Table 48. Global Testosterone Undecanoate Revenue Share by Application (2023-2028)

Table 49. Global Testosterone Undecanoate Price (K Units) by Application (2023-2028)

Table 50. North America Testosterone Undecanoate Sales by Company (2017-2022) & (K Units)

Table 51. North America Testosterone Undecanoate Sales Market Share by Company (2017-2022)

Table 52. North America Testosterone Undecanoate Revenue by Company (2017-2022) & (US$ Million)

Table 53. North America Testosterone Undecanoate Revenue Market Share by Company (2017-2022)

Table 54. North America Testosterone Undecanoate Sales by Type (2017-2022) & (K Units)

Table 55. North America Testosterone Undecanoate Sales by Type (2023-2028) & (K Units)

Table 56. North America Testosterone Undecanoate Revenue by Type (2017-2022) & (US$ Million)

Table 57. North America Testosterone Undecanoate Revenue by Type (2023-2028) & (US$ Million)

Table 58. North America Testosterone Undecanoate Sales by Application (2017-2022) & (K Units)

Table 59. North America Testosterone Undecanoate Sales by Application (2023-2028) & (K Units)

Table 60. North America Testosterone Undecanoate Revenue by Application (2017-2022) & (US$ Million)

Table 61. North America Testosterone Undecanoate Revenue by Application (2023-2028) & (US$ Million)

Table 62. North America Testosterone Undecanoate Sales by Country (2017-2022) & (K Units)

Table 63. North America Testosterone Undecanoate Sales by Country (2023-2028) & (K Units)

Table 64. North America Testosterone Undecanoate Revenue by Country (2017-2022) & (US$ Million)

Table 65. North America Testosterone Undecanoate Revenue by Country (2023-2028) & (US$ Million)

Table 66. Europe Testosterone Undecanoate Sales by Company (2017-2022) & (K Units)

Table 67. Europe Testosterone Undecanoate Sales Market Share by Company (2017-2022)

Table 68. Europe Testosterone Undecanoate Revenue by Company (2017-2022) & (US$ Million)

Table 69. Europe Testosterone Undecanoate Revenue Market Share by Company (2017-2022)

Table 70. Europe Testosterone Undecanoate Sales by Type (2017-2022) & (K Units)

Table 71. Europe Testosterone Undecanoate Sales by Type (2023-2028) & (K Units)

Table 72. Europe Testosterone Undecanoate Revenue by Type (2017-2022) & (US$ Million)

Table 73. Europe Testosterone Undecanoate Revenue by Type (2023-2028) & (US$ Million)

Table 74. Europe Testosterone Undecanoate Sales by Application (2017-2022) & (K Units)

Table 75. Europe Testosterone Undecanoate Sales by Application (2023-2028) & (K Units)

Table 76. Europe Testosterone Undecanoate Revenue by Application (2017-2022) & (US$ Million)

Table 77. Europe Testosterone Undecanoate Revenue by Application (2023-2028) & (US$ Million)

Table 78. Europe Testosterone Undecanoate Sales by Country (2017-2022) & (K Units)

Table 79. Europe Testosterone Undecanoate Sales by Country (2023-2028) & (K Units)

Table 80. Europe Testosterone Undecanoate Revenue by Country (2017-2022) & (US$ Million)

Table 81. Europe Testosterone Undecanoate Revenue by Country (2023-2028) & (US$ Million)

Table 82. Asia Pacific Testosterone Undecanoate Sales by Company (2017-2022) & (K Units)

Table 83. Asia Pacific Testosterone Undecanoate Sales Market Share by Company (2017-2022)

Table 84. Asia Pacific Testosterone Undecanoate Revenue by Company (2017-2022) & (US$ Million)

Table 85. Asia Pacific Testosterone Undecanoate Revenue Market Share by Company (2017-2022)

Table 86. Asia Pacific Testosterone Undecanoate Sales by Type (2017-2022) & (K Units)

Table 87. Asia Pacific Testosterone Undecanoate Sales by Type (2023-2028) & (K Units)

Table 88. Asia Pacific Testosterone Undecanoate Revenue by Type (2017-2022) & (US$ Million)

Table 89. Asia Pacific Testosterone Undecanoate Revenue by Type (2023-2028) & (US$ Million)

Table 90. Asia Pacific Testosterone Undecanoate Sales by Application (2017-2022) & (K Units)

Table 91. Asia Pacific Testosterone Undecanoate Sales by Application (2023-2028) & (K Units)

Table 92. Asia Pacific Testosterone Undecanoate Revenue by Application (2017-2022) & (US$ Million)

Table 93. Asia Pacific Testosterone Undecanoate Revenue by Application (2023-2028) & (US$ Million)

Table 94. Asia Pacific Testosterone Undecanoate Sales by Region (2017-2022) & (K Units)

Table 95. Asia Pacific Testosterone Undecanoate Sales by Region (2023-2028) & (K Units)

Table 96. Asia Pacific Testosterone Undecanoate Revenue by Region (2017-2022) & (US$ Million)

Table 97. Asia Pacific Testosterone Undecanoate Revenue by Region (2023-2028) & (US$ Million)

Table 98. Latin America Testosterone Undecanoate Sales by Company (2017-2022) & (K Units)

Table 99. Latin America Testosterone Undecanoate Sales Market Share by Company (2017-2022)

Table 100. Latin America Testosterone Undecanoate Revenue by Company (2017-2022) & (US$ Million)

Table 101. Latin America Testosterone Undecanoate Revenue Market Share by Company (2017-2022)

Table 102. Latin America Testosterone Undecanoate Sales by Type (2017-2022) & (K Units)

Table 103. Latin America Testosterone Undecanoate Sales by Type (2023-2028) & (K Units)

Table 104. Latin America Testosterone Undecanoate Revenue by Type (2017-2022) & (US$ Million)

Table 105. Latin America Testosterone Undecanoate Revenue by Type (2023-2028) & (US$ Million)

Table 106. Latin America Testosterone Undecanoate Sales by Application (2017-2022) & (K Units)

Table 107. Latin America Testosterone Undecanoate Sales by Application (2023-2028) & (K Units)

Table 108. Latin America Testosterone Undecanoate Revenue by Application (2017-2022) & (US$ Million)

Table 109. Latin America Testosterone Undecanoate Revenue by Application (2023-2028) & (US$ Million)

Table 110. Latin America Testosterone Undecanoate Sales by Country (2017-2022) & (K Units)

Table 111. Latin America Testosterone Undecanoate Sales by Country (2023-2028) & (K Units)

Table 112. Latin America Testosterone Undecanoate Revenue by Country (2017-2022) & (US$ Million)

Table 113. Latin America Testosterone Undecanoate Revenue by Country (2023-2028) & (US$ Million)

Table 114. Middle East and Africa Testosterone Undecanoate Sales by Company (2017-2022) & (K Units)

Table 115. Middle East and Africa Testosterone Undecanoate Sales Market Share by Company (2017-2022)

Table 116. Middle East and Africa Testosterone Undecanoate Revenue by Company (2017-2022) & (US$ Million)

Table 117. Middle East and Africa Testosterone Undecanoate Revenue Market Share by Company (2017-2022)

Table 118. Middle East and Africa Testosterone Undecanoate Sales by Type (2017-2022) & (K Units)

Table 119. Middle East and Africa Testosterone Undecanoate Sales by Type (2023-2028) & (K Units)

Table 120. Middle East and Africa Testosterone Undecanoate Revenue by Type (2017-2022) & (US$ Million)

Table 121. Middle East and Africa Testosterone Undecanoate Revenue by Type (2023-2028) & (US$ Million)

Table 122. Middle East and Africa Testosterone Undecanoate Sales by Application (2017-2022) & (K Units)

Table 123. Middle East and Africa Testosterone Undecanoate Sales by Application (2023-2028) & (K Units)

Table 124. Middle East and Africa Testosterone Undecanoate Revenue by Application (2017-2022) & (US$ Million)

Table 125. Middle East and Africa Testosterone Undecanoate Revenue by Application (2023-2028) & (US$ Million)

Table 126. Middle East and Africa Testosterone Undecanoate Sales by Country (2017-2022) & (K Units)

Table 127. Middle East and Africa Testosterone Undecanoate Sales by Country (2023-2028) & (K Units)

Table 128. Middle East and Africa Testosterone Undecanoate Revenue by Country (2017-2022) & (US$ Million)

Table 129. Middle East and Africa Testosterone Undecanoate Revenue by Country (2023-2028) & (US$ Million)

Table 130. Bayer AG Corporation Information

Table 131. Bayer AG Description and Overview

Table 132. Bayer AG Testosterone Undecanoate Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)

Table 133. Bayer AG Testosterone Undecanoate Product and Services

Table 134. Bayer AG Testosterone Undecanoate SWOT Analysis

Table 135. Bayer AG Recent Developments

Table 136. Endo Pharmaceuticals Corporation Information

Table 137. Endo Pharmaceuticals Description and Overview

Table 138. Endo Pharmaceuticals Testosterone Undecanoate Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)

Table 139. Endo Pharmaceuticals Testosterone Undecanoate Product and Services

Table 140. Endo Pharmaceuticals Testosterone Undecanoate SWOT Analysis

Table 141. Endo Pharmaceuticals Recent Developments

Table 142. Merck Sharp & Dohme Corporation Information

Table 143. Merck Sharp & Dohme Description and Overview

Table 144. Merck Sharp & Dohme Testosterone Undecanoate Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)

Table 145. Merck Sharp & Dohme Testosterone Undecanoate Product and Services

Table 146. Merck Sharp & Dohme Testosterone Undecanoate SWOT Analysis

Table 147. Merck Sharp & Dohme Recent Developments

Table 148. Taro Pharmaceutical Corporation Information

Table 149. Taro Pharmaceutical Description and Overview

Table 150. Taro Pharmaceutical Testosterone Undecanoate Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)

Table 151. Taro Pharmaceutical Testosterone Undecanoate Product and Services

Table 152. Taro Pharmaceutical Testosterone Undecanoate SWOT Analysis

Table 153. Taro Pharmaceutical Recent Developments

Table 154. Cipla Corporation Information

Table 155. Cipla Description and Overview

Table 156. Cipla Testosterone Undecanoate Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)

Table 157. Cipla Testosterone Undecanoate Product and Services

Table 158. Cipla Testosterone Undecanoate SWOT Analysis

Table 159. Cipla Recent Developments

Table 160. Zhejiang Xianju Pharmaceutical Corporation Information

Table 161. Zhejiang Xianju Pharmaceutical Description and Overview

Table 162. Zhejiang Xianju Pharmaceutical Testosterone Undecanoate Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)

Table 163. Zhejiang Xianju Pharmaceutical Testosterone Undecanoate Product and Services

Table 164. Zhejiang Xianju Pharmaceutical Testosterone Undecanoate SWOT Analysis

Table 165. Zhejiang Xianju Pharmaceutical Recent Developments

Table 166. Zhejiang Medicine Co. Corporation Information

Table 167. Zhejiang Medicine Co. Description and Overview

Table 168. Zhejiang Medicine Co. Testosterone Undecanoate Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)

Table 169. Zhejiang Medicine Co. Testosterone Undecanoate Product and Services

Table 170. Zhejiang Medicine Co. Testosterone Undecanoate SWOT Analysis

Table 171. Zhejiang Medicine Co. Recent Developments

Table 172. Key Raw Materials Lists

Table 173. Raw Materials Key Suppliers Lists

Table 174. Testosterone Undecanoate Distributors List

Table 175. Testosterone Undecanoate Customers List

Table 176. Research Programs/Design for This Report

Table 177. Key Data Information from Secondary Sources

Table 178. Key Data Information from Primary Sources

List of Figures

Figure 1. Testosterone Undecanoate Product Picture

Figure 2. Global Testosterone Undecanoate Sales Market Share by Type in 2021 & 2028

Figure 3. Injection Product Picture

Figure 4. Oral Product Picture

Figure 5. Global Testosterone Undecanoate Sales Market Share by Application in 2021 & 2028

Figure 6. Primary Hypogonadism Use Case

Figure 7. Hypogonadotropic Hypogonadism Use Case

Figure 8. Late-Onset Hypogonadism Use Case

Figure 9. Testosterone Undecanoate Report Years Considered

Figure 10. Global Testosterone Undecanoate Revenue, (US$ Million), 2017 VS 2021 VS 2028

Figure 11. Global Testosterone Undecanoate Market Size 2017-2028 (US$ Million)

Figure 12. Global Testosterone Undecanoate Sales (2017-2022) & (K Units)

Figure 13. Global Testosterone Undecanoate Market Size Market Share by Region: 2021 VS 2028

Figure 14. Global Testosterone Undecanoate Sales Market Share by Region (2017-2022)

Figure 15. Global Testosterone Undecanoate Sales Market Share by Region in 2021

Figure 16. Global Testosterone Undecanoate Revenue Market Share by Region in 2017 VS 2021

Figure 17. Global Testosterone Undecanoate Sales Share by Manufacturers in 2021

Figure 18. The 5 and 10 Largest Manufacturers in the World: Market Share by Testosterone Undecanoate Sales in 2021

Figure 19. Testosterone Undecanoate Revenue Share by Manufacturers in 2021

Figure 20. Testosterone Undecanoate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021

Figure 21. Global Testosterone Undecanoate Revenue Share by Type (2017-2022)

Figure 22. Global Testosterone Undecanoate Revenue Growth Rate by Type in 2017 & 2021

Figure 23. Global Testosterone Undecanoate Revenue Share by Application (2017-2022)

Figure 24. Global Testosterone Undecanoate Revenue Growth Rate by Application in 2017 & 2021

Figure 25. North America Testosterone Undecanoate Sales Market Share by Type (2017-2028)

Figure 26. North America Testosterone Undecanoate Revenue Market Share by Type (2017-2028)

Figure 27. North America Testosterone Undecanoate Sales Market Share by Application (2017-2028)

Figure 28. North America Testosterone Undecanoate Revenue Market Share by Application (2017-2028)

Figure 29. North America Testosterone Undecanoate Sales Share by Country (2017-2028)

Figure 30. North America Testosterone Undecanoate Revenue Share by Country (2017-2028)

Figure 31. U.S. Testosterone Undecanoate Revenue (2017-2028) & (US$ Million)

Figure 32. Canada Testosterone Undecanoate Revenue (2017-2028) & (US$ Million)

Figure 33. Europe Testosterone Undecanoate Sales Market Share by Type (2017-2028)

Figure 34. Europe Testosterone Undecanoate Revenue Market Share by Type (2017-2028)

Figure 35. Europe Testosterone Undecanoate Sales Market Share by Application (2017-2028)

Figure 36. Europe Testosterone Undecanoate Revenue Market Share by Application (2017-2028)

Figure 37. Europe Testosterone Undecanoate Sales Share by Country (2017-2028)

Figure 38. Europe Testosterone Undecanoate Revenue Share by Country (2017-2028)

Figure 39. Germany Testosterone Undecanoate Revenue (2017-2028) & (US$ Million)

Figure 40. France Testosterone Undecanoate Revenue (2017-2028) & (US$ Million)

Figure 41. U.K. Testosterone Undecanoate Revenue (2017-2028) & (US$ Million)

Figure 42. Italy Testosterone Undecanoate Revenue (2017-2028) & (US$ Million)

Figure 43. Russia Testosterone Undecanoate Revenue (2017-2028) & (US$ Million)

Figure 44. Asia Pacific Testosterone Undecanoate Sales Market Share by Type (2017-2028)

Figure 45. Asia Pacific Testosterone Undecanoate Revenue Market Share by Type (2017-2028)

Figure 46. Asia Pacific Testosterone Undecanoate Sales Market Share by Application (2017-2028)

Figure 47. Asia Pacific Testosterone Undecanoate Revenue Market Share by Application (2017-2028)

Figure 48. Asia Pacific Testosterone Undecanoate Sales Share by Region (2017-2028)

Figure 49. Asia Pacific Testosterone Undecanoate Revenue Share by Region (2017-2028)

Figure 50. China Testosterone Undecanoate Revenue (2017-2028) & (US$ Million)

Figure 51. Japan Testosterone Undecanoate Revenue (2017-2028) & (US$ Million)

Figure 52. South Korea Testosterone Undecanoate Revenue (2017-2028) & (US$ Million)

Figure 53. India Testosterone Undecanoate Revenue (2017-2028) & (US$ Million)

Figure 54. Australia Testosterone Undecanoate Revenue (2017-2028) & (US$ Million)

Figure 55. Taiwan Testosterone Undecanoate Revenue (2017-2028) & (US$ Million)

Figure 56. Indonesia Testosterone Undecanoate Revenue (2017-2028) & (US$ Million)

Figure 57. Thailand Testosterone Undecanoate Revenue (2017-2028) & (US$ Million)

Figure 58. Malaysia Testosterone Undecanoate Revenue (2017-2028) & (US$ Million)

Figure 59. Philippines Testosterone Undecanoate Revenue (2017-2028) & (US$ Million)

Figure 60. Vietnam Testosterone Undecanoate Revenue (2017-2028) & (US$ Million)

Figure 61. Latin America Testosterone Undecanoate Sales Market Share by Type (2017-2028)

Figure 62. Latin America Testosterone Undecanoate Revenue Market Share by Type (2017-2028)

Figure 63. Latin America Testosterone Undecanoate Sales Market Share by Application (2017-2028)

Figure 64. Latin America Testosterone Undecanoate Revenue Market Share by Application (2017-2028)

Figure 65. Latin America Testosterone Undecanoate Sales Share by Country (2017-2028)

Figure 66. Latin America Testosterone Undecanoate Revenue Share by Country (2017-2028)

Figure 67. Mexico Testosterone Undecanoate Revenue (2017-2028) & (US$ Million)

Figure 68. Brazil Testosterone Undecanoate Revenue (2017-2028) & (US$ Million)

Figure 69. Argentina Testosterone Undecanoate Revenue (2017-2028) & (US$ Million)

Figure 70. Middle East and Africa Testosterone Undecanoate Sales Market Share by Type (2017-2028)

Figure 71. Middle East and Africa Testosterone Undecanoate Revenue Market Share by Type (2017-2028)

Figure 72. Middle East and Africa Testosterone Undecanoate Sales Market Share by Application (2017-2028)

Figure 73. Middle East and Africa Testosterone Undecanoate Revenue Market Share by Application (2017-2028)

Figure 74. Middle East and Africa Testosterone Undecanoate Sales Share by Country (2017-2028)

Figure 75. Middle East and Africa Testosterone Undecanoate Revenue Share by Country (2017-2028)

Figure 76. Turkey Testosterone Undecanoate Revenue (2017-2028) & (US$ Million)

Figure 77. Saudi Arabia Testosterone Undecanoate Revenue (2017-2028) & (US$ Million)

Figure 78. UAE Testosterone Undecanoate Revenue (2017-2028) & (US$ Million)

Figure 79. Testosterone Undecanoate Value Chain

Figure 80. Testosterone Undecanoate Production Process

Figure 81. Channels of Distribution

Figure 82. Distributors Profiles

Figure 83. Bottom-up and Top-down Approaches for This Report

Figure 84. Data Triangulation

Figure 85. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$5600

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$8400

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$11200

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Global Testosterone Undecanoate Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Published Date: September 2022

Report Code: QYRE-Auto-2Z12319

Global Testosterone Undecanoate Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

FEATURED COMPANIES

Testosterone Undecanoate Segment by Type

Testosterone Undecanoate Segment by Application

FEATURED COMPANIES

RELATED REPORTS